Real-world US Experience with Voxelotor for Sickle Cell Disease: A Plain Language Summary of the RETRO and PROSPECT studies
Biree Andemariam · 2026
Read Real-world US Experience with Voxelotor for Sickle Cell Disease: A Plain Language Summary of the RETRO and PROSPECT studies by Biree Andemariam (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13420057.txt.
Description
Biree Andemariam presents a plain language summary of two real-world studies of voxelotor, a drug for sickle cell disease used in everyday practice. Sickle cell disease deforms red blood cells and destroys them early, leaving patients anemic and at risk of organ damage. The summary restates the RETRO and PROSPECT study results in words meant for patients and families.
The RETRO study enrolled 216 participants, who stayed on the drug for about a year on average across the group. Hemoglobin, the oxygen-carrying protein that this disease depletes, rose after treatment began. Findings from routine care matter because trial volunteers rarely match the full patient population. A clear summary like this one helps families weigh the drug beside their doctors.
Catalog record
| CREATOR | Biree Andemariam |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |